How do probiotic targeted release tablets ensure a high survival rate of live bacteria even under the combined effects of stomach acid, pancreatic enzymes, and bile?
Publish Time: 2026-06-08
With the increasing demand for gut health management, probiotic targeted release tablets are widely used in various fields such as gut microbiota regulation, digestive function improvement, and immune system maintenance. However, after entering the human body, ordinary probiotics need to pass through the complex digestive environment of the stomach and small intestine, where they are continuously exposed to stomach acid, pancreatic enzymes, bile, and various digestive juices. A large number of live bacteria become inactive before reaching the site of action, significantly affecting the actual colonization effect.1. Utilizing targeted release coating technology to build multiple protective barriersStomach acid is the first major challenge probiotics face after entering the human body. Under normal circumstances, the pH value in the stomach is low, and the highly acidic environment can damage the cell structure of probiotics, causing a large number of bacteria to die. Probiotic targeted release tablets use a special acid-resistant coating system that maintains structural stability in the stomach environment, forming an effective physical barrier layer to prevent direct contact between stomach acid and the bacteria. Meanwhile, the coating material responds to changes in pH levels in different digestive tract regions, gradually dissolving and releasing at preset locations, allowing probiotics to pass smoothly through the stomach environment and improving the protection of live bacteria from the source.2. Optimized Core Tablet Formulation Enhances Enzyme ResistanceBesides the effects of stomach acid, pancreatic enzymes in the small intestine can also damage probiotics. Pancreatic enzymes have a strong protein-degrading ability, easily damaging bacterial cell membranes and cell wall structures. To address this issue, targeted release tablets improve the stability of probiotics in an enzyme environment by optimizing the core tablet formulation. The core tablet typically employs an appropriate tablet weight, dense structure, and regular tablet shape design, ensuring that active bacteria are evenly dispersed within the protective matrix, and utilizing a multi-layer coating process to further reduce the penetration rate of digestive enzymes. This not only enhances bacterial tolerance but also reduces activity loss during transportation and storage.3. Utilizing a Hydrophobic Barrier to Reduce Bile DamageBile is mainly secreted in the duodenum region and has strong surface activity and alkaline characteristics, which can disrupt the cell membrane structure of probiotics and affect bacterial activity. In particular, the survival rate of some sensitive strains decreases significantly when passing through bile regions. Probiotic targeted release technology fully utilizes the hydrophobic properties of the coating material to form a stable protective layer on the outside of the bacteria, reducing direct contact between bile and the bacteria. Simultaneously, by controlling the coating thickness and dissolution rate, the product can smoothly pass through the bile secretion area, effectively reducing bile salt damage to the cell membrane and improving the overall survival rate of the strains.4. Achieving Precise Release in the Terminal Small Intestine to Improve Colonization EfficiencyTraditional probiotic products often release pre-emptively in the stomach or the early small intestine, resulting in a large number of live bacteria being exposed to the complex digestive environment. Probiotic targeted release tablets use targeted release technology, precisely controlling the coating dissolution threshold to release the product in the terminal small intestine or ileum. Since the effects of gastric acid, pancreatic enzymes, and most of the bile have been avoided at this point, live bacteria can enter the large intestine with a higher survival rate. Once more active bacteria reach the target area, they can quickly participate in intestinal flora reconstruction, increasing the colonization quantity and duration of action, thereby enhancing the product's actual application effect.5. Comprehensive Coverage of the Entire Digestive Tract for Combined Treatment of Multiple Intestinal IssuesProbiotic targeted release tablets not only possess advantages such as acid resistance, enzyme resistance, and bile resistance, but also feature a multi-layered release structure designed according to the characteristics of different strains, achieving comprehensive protection of the entire digestive tract. Some strains can exert their effects in the upper digestive tract, while more core bacteria can safely enter the large intestine to complete colonization. By improving the survival rate of live bacteria and the precision of release, the product can more effectively regulate the balance of the intestinal microecology, suitable for the comprehensive treatment needs of dysbiosis, decreased digestive function, intestinal sensitivity, and various intestinal health problems.In summary, probiotic targeted release tablets, through the synergistic effect of multiple technologies such as acid-resistant coating, multi-layered protective structure, enzyme-resistant design, anti-bile barrier, and precise release at the terminal small intestine, effectively solve the problem of easy inactivation of probiotics in the digestive tract. Compared with traditional probiotic preparations, this technology can significantly improve the survival rate and colonization efficiency of live bacteria, allowing more active probiotics to safely reach the large intestine and continue to exert their effects, providing a more reliable technical guarantee for intestinal health management.
